Available online on 15.06.2022 at ijmspr.com
International Journal of Medical Sciences and Pharma Research
Open Access to Medical and Research
Copyright © 2022 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Process Validation of Sevelamer Hydrochloride Film Coated Tablet
Basant Kumar Yadav 1*, Neetesh Kumar Jain2, Apoorva Tiwari1, Supriya Shidhaye3
1 Department of Quality Assurance, Faculty of Pharmacy, Oriental University Indore-India
2 Department of Pharmacology, Faculty of Pharmacy, Oriental University Indore-India
3 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Oriental University Indore-India
|
Article Info: _____________________________________________ Article History: Received 19 April 2022 Reviewed 30 May 2022 Accepted 09 June 2022 Published 15 June 2022 _____________________________________________ Cite this article as: Yadav BK, Jain NK, Tiwari A, Shidhaye S, Process Validation of Sevelamer Hydrochloride Film Coated Tablet, International Journal of Medical Sciences & Pharma Research, 2022; 8(2):65-71 DOI: http://dx.doi.org/10.22270/ijmspr.v8i2.41 ____________________________________________ *Address for Correspondence: Basant Kumar Yadav, Department of Quality Assurance, Faculty of Pharmacy, Oriental University Indore-India |
Abstract ___________________________________________________________________________________________________________________ All the three batches resulted in granules with desired flow and compaction which is evident from the data of compressed tablets. At compression stage Weight parameters and Speed parameters evaluated and found within Specified limit as well as, The Statistical analysis process performance is high capable, Data is normal and Z bench value also give assurance that process remains in state of control (Process validation state) during manufacturing of Sevelamer Hydrochloride film coated tablets, 800 mg. Coating process proven as validated from the weight build up data of tablets as validation data provided for after 50% coating, 75% coating and 100% coating and found in accordance with process validation protocol. Finished product result was evidence of Weight gain while the inspection activity as this material is in very high hygroscopic in nature. However results found within specified limit. Keywords: Z bench value, Sevelamer Hydrochloride, Process validation, cGMP.
|
Email: basantyadav39@gmail.com
INTRODUCTION:
Validation is a tool of quality assurance which provides confirmation of the quality in equipment system, manufacturing process, software and testing methods. Validation of the individual step of manufacturing processes is called the process validation. The concept of validation was first proposed by two Food and Drug Administration (FDA) officials, Ted Byers and Bud Loftus, in the mid-1970s in order to improve the quality of pharmaceuticals Assurance of product quality is derived from careful attention to number of factors including selection of quality parts and materials, adequate product and process design, control of the process, and in process and end product testing. 1
Process Validation has now become a part of Current Good Manufacturing Practices Regulations (cGMP), it is mandatory for manufacturer to go through Process Validation much more rigorously than earlier. 2
Types of Validation
Drug Profile:
|
Sr.No |
Parameter |
SEVELAMER HYDROCLORIDE |
|
1. |
Structure |
|
|
2. |
IUPAC name |
2-(chloromethyl)oxirane prop-2-en-1-amine hydrochloride |
|
3. |
Category |
Phosphate binding agent |
|
4. |
Molecular formula |
C6H12Cl2NO |
|
5. |
Molecular weight |
186.08 g/mol |
|
6. |
CAS registry number |
152751-57-0 |
|
7. |
Solubility |
Insoluble in water |
|
8. |
pKa value |
-4.2 |
|
9. |
Melting Point |
298 °C to 304 °C |
|
10. |
CDSCO Approval |
10-07-2007 |
|
11. |
Storage |
Store at controlled room temperature 15°C to 30°C. Protect from moisture. |
|
12. |
Use |
Hyperphosphatemia, Renal dialysis |
|
13. |
Mechanism of action |
Sevelamer is a non-absorbable polymeric amine and phosphate binding agent which is used to prevent hyperphosphatemia. Upon oral administration, the amine groups in sevelamer become protonated in the intestines and bind to the dietary phosphate groups in the gastrointestinal tract, through preventing the absorption of phosphate and controlling the phosphate plasma level. |
Purpose of Validation:
The purpose of this validation study is establishing documented evidence that the specified manufacturing process employed to manufacture Sevelamr Hydrochloride film coated tablets, 800 mg is capable of producing the product meeting all its predetermined specifications and quality attributes consistently and reproducibly. Before any batch from the process is commercially distributed for use by consumers, a manufacturer should have gained a high degree of assurance in the performance of the manufacturing process such that it will consistently produce drug products meeting those attributes relating to identity, strength, quality. purity, and potency. The assurance should be obtained from objective information and data from laboratory and exhibit batches. Information and data should demonstrate that the manufacturing process is capable of consistently producing acceptable quality products within manufacturing conditions. A successful validation program depends upon information and knowledge from product and preset the development. This knowledge and understanding is the basis for establishing an approach to control of the manufacturing process those results in products with the desired quality attributes.
Quality Assurance:
Quality Control:
List of Equipments/Instruments:
|
S. N. |
EQUIPMENT/ INSTRUMENTS NAME |
|
01 |
Weighing balance (Dispensing - 100 kg, 10 Kg & 300 mg) |
|
02 |
Weighing balance (Granulation area - 200 kg) |
|
03 |
Vibrorotatory Sifter (20#, 30# and 60#) |
|
04 |
Octagonal blender (300 L) |
|
05 |
Compression Machine 15 Station D tooling Machine |
|
06 |
De-duster |
|
07 |
Metal detector |
|
08 |
Weighing balance (Compression Quarantine - 200 kg) |
|
09 |
Weighing balance (IPQC - 220 mg) |
|
10 |
Vernier caliper |
|
11 |
Hardness tester |
|
12 |
Friabilator |
|
13 |
Disintegration Apparatus |
|
14 |
Solution Preparation tank |
|
15 |
Solution tank with stirrer |
|
16 |
Auto coater 48” (125 Kg) |
|
17 |
Weighing balance (Coating Quarantine - 200 kg) |
|
18 |
Inspection table |
|
19 |
Weighing balance (Inspection Quarantine - 200 kg) |
Process Flow Diagram: Process Flow Diagram
|
EQUIPMENTS/ INSTRUMENTS |
PROCESS |
CHECKS |
|
Weighing balance (100 kg, 10 Kg & 300 mg) |
Dispensing of Raw materials
|
|
|
Weighing balance (200 kg) |
Verification of dispensed Material
|
|
|
Vibratory Sifter 30#, 20# |
Sifting of raw materials
|
|
|
Octagonal Blender (300 L) |
Blending of sifted raw materials
|
|
|
Vibratory Sifter 60# |
Sifting of lubrication material
|
|
|
EQUIPMENTS/ INSTRUMENTS |
PROCESS |
CHECKS |
|
Octagonal Blender (300 L), Containers and Weighing balance (200 kg) |
Blending of lubrication material
|
|
|
Compression machine 15 station, Containers, Weighing balance (200 Kg), Weighing balance (220 mg), Vernier caliper, Hardness tester, Friabilator, Disintegration Apparatus, De- duster and metal detector |
Tablet Compression
|
|
|
Solution preparation tank, soltion tank with stirrer, Autocoater 48” (125 Kg), weighing balance 200 Kg and containers. |
Tablet Coating
|
|
|
EQUIPMENTS/ INSTRUMENTS |
PROCESS |
CHECKS |
|
Weighing balance (100 kg, 10 Kg & 300 mg) |
Dispensing of Raw materials
|
|
|
Weighing balance (200 kg) |
Verification of dispensed Material
|
|
|
Vibratory Sifter 30#, 20# |
Sifting of raw materials
|
|
|
Octagonal Blender (300 L) |
Blending of sifted raw materials
|
|
|
Vibratory Sifter 60# |
Sifting of lubrication material
|
|
|
EQUIPMENTS/ INSRUMTENTS |
PROCESS |
CHECKS |
|
Octagonal Blender (300 L), Containers and Weighing balance (200 kg) |
Blending of lubrication material
|
|
|
Compression machine 15 station, Containers, Weighing balance (200 Kg), Weighing balance (220 mg), Vernier caliper, Hardness tester, Friabilator, Disintegration Apparatus, De- duster and metal detector |
Tablet Compression
|
|
|
Solution preparation tank, soltion tank with stirrer, Autocoater 48” (125 Kg), weighing balance 200 Kg and containers. |
Tablet Coating
|
|
|
EQUIPMENTS/ INSTRUMENTS |
PROCESS |
CHECKS |
|
Inspection table, Containers SS tray, Weighing balance (200 Kg), |
Visual Inspection
|
|
CONCLUSION:
The manufacturing process of Sevelamer Hydrochloride film coated tablets, 800 mg carried out as per the MBMR and Process validation protocol. Which include sifting, blending, compression and coating. All the material used for the manufacturing of tablets were tested as per the given specification and the results were within the limits. Ø Process is designed by the Quality Assurance in protocol, Production has to adhere to the requirements of the protocol, Quality Control has to analyse the sample and sent report to Quality Assurance department. All the equipments used in the manufacturing of the Sevelamer Hydrochloride filmcoated tablets, 800 mg were checked for its Installation, operational and performance qualification. Blending time of Raw material at 08 RPM for 30 minutes and Blending time with Lubrication material at 08 RPM for 08 minutes concluded as validated. The granulation process i.e. Dry granulation in place of wet granulation process was validated for Sevelamer Hydrochloride film coated tablets, 800 mg. All the three batches resulted in granules with desired flow and compaction which is evident from the data of compressed tablets. At compression stage Weight parameters and Speed parameters evaluated and found within Specified limit as well as, The Statistical analysis process performance is high capable, Data is normal and Z bench value also give assurance that process remains in state of control (Process validation state) during manufacturing of Sevelamer Hydrochloride film coated tablets, 800 mg.
REFERENCES:
1. Umed AN, Abhijit VJ, Salunke VR, Magdum CS, "An Overview of Pharmaceutical Process Validation of Solid Dosage Form." Current Pharma Research, 2013; 824-835. https://doi.org/10.33786/JCPR.2013.v03i02.006
2. Vikas V, Ujjwal N, Senthil Kumar M, Chandrakant , "Process Validation of Tablet: An Overview." Asian Pacific Journal of Health Science, 2014; 1(1):31-38. https://doi.org/10.21276/apjhs.2014.1.1.5
3. Guideline on General Principles of Process Validation, FDA, DRH/CDER, 1987.
4. European Commission, Qualification and Validation, Annex 15 to the EU guide to GMP. Brussels, 2001.
5. USFDA Guidance for industry "Process validation: general principles and practices." 2011.
6. Committee on specifications for manufacturing practices for pharmaceutical products, WHO technical report series no. 82, Geneva: world health organization, 1992; 14-79.
7. Manasa SR, Chandramauli R, "Functional Overview of Process Validation of tablet: A critical Review." Journal of pharmaceutical Research; 2017; 16(3):268-277. https://doi.org/10.18579/jpcrkc/2017/16/3/118767
8. Satinder Kumar, "Pharmaceutical Process Validation: A CGMP Concept", PharmaTutor; 2015.
9. Mahato TK, Sharma K, Study of medicinal herbs and its antibacterial activity: A review, Journal of Drug Delivery and Therapeutics 2018; 8(5-s):47-54
10. Chandan S, Rana AC, Rajni B, Nimrata S, "An Overview of Industrial Process Validation of Tablets." Journal of Drug Delivery and Therapeutics; 2013; 3(3):175-183. https://doi.org/10.22270/jddt.v3i3.489
11. Harpreet K, Gurpreet S, Nimarata S, "Pharmaceutical Process Validation -A Review." Journal of Drug Delivery and Therapeutics; 2013; 3(4):189- 194. https://doi.org/10.22270/jddt.v3i4.547
12. Sharma PP, Validation In Pharmaceutical Industry, 5th Edn; Vandana Publications, Delhi, 2013. https://doi.org/10.22270/jddt.v3i4.582
13. Kamlesh D, Deependra S, Swarnlata S, Saraf S, "Validation - Essential Quality Assurance Tool for Pharma Industries." , 2005; 45-47.
14. Sindhurnag N, Gouthami B, Madhuri L, Lavanya RV, Krishnaveni N and et al, " The Concept of Process Validation in tablet manufacturing : Review," Journal of Pharmacy Research ; 2012;, 5(2):1264-1267